骨髓灰质炎和COVID-19:一个系统审查和元分析
Amirhossein Nafari1, Seyedpouzhia Shojaei2, Reza Jalili Khoshnood3
1Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Basic and clinical neuroscience
|September 4, 2024
概括
在肌痛性骨髓灰质炎 (MG) 患者中,COVID-19感染的综合流行率为2%. 这次系统性审查和元分析分析了18项研究,以确定MG患者的COVID-19感染率.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 自身免疫性疾病 自身免疫性疾病
背景情况:
- 骨髓灰质炎 (MG) 是一种自身免疫性神经肌肉结合障碍.
- 在MG患者中,COVID-19感染率因研究而异.
- 了解MG中的COVID-19流行率对于患者管理至关重要.
研究的目的:
- 为了估计COVID-19感染在患有骨髓质疏松症的个体中的综合流行率.
- 综合现有的关于MG患者COVID-19的研究.
主要方法:
- 在PubMed,Scopus,EMBASE,Web of Science,Google Scholar和灰色文学中进行系统的文献搜索,截至2021年10月.
- 从最初的253件中删除重复件后,包括18件物品.
- 数据提取包括参与者数量,MG患者数量,症状,住院和死亡率.
主要成果:
- 在MG患者中,COVID-19感染的综合流行率为2% (95% CI,1%-3%).
- 感染MG患者的住院患病率为43% (95%CI,26-60%).
- MG恶化发生率为33% (95% CI,20%-46%).
结论:
- 在患有骨髓灰质炎的个体中,COVID-19感染的综合流行率为2%.
- 许多患有COVID-19的MG患者经历了住院治疗和疾病恶化.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Myasthenia Gravis: Diagnostic Tests
705
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
705
Disorders of the Skeletal Muscle
905
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
905
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.2K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.2K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


